Breaking News

ResearchDx Completes Relocation

By Gil Roth | July 22, 2013

Celebrates move with open house event

ResearchDx has completed the purchase, build-out and relocation of its 30,000-sq.-ft. facility in Irvine, CA. The custom-designed facility will support the company's expansion of in vitro diagnostic (IVD) development services to the pharma, biotechnology, diagnostic development and clinical laboratory industries.

To celebrate this event, ResearchDx will be holding an open house on Tuesday, July 23 from 1-7 p.m. The event is open to anyone with a professional or personal interest in diagnostics and diagnostic development. Laboratory tours and technology presentations will be conducted throughout the afternoon, and food and beverages will be served. For more information regarding this event please contact Natalie McCan at

ResearchDx provides integrated, flexible services for the IVD development process, including initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, as well clinical research services and regulatory approval.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important